GO:0106001 intestinal hexose absorption: Transcellular Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0106001 intestinal hexose absorption is the biological process by which hexoses, notably D-glucose, fructose, and galactose, are taken up from the small intestine into the blood.
• The process involves both transcellular and paracellular routes, with the transcellular pathway mediated by apically located sodium-dependent glucose transporters and basolaterally located facilitative glucose transporters.
• Key genes include SLC5A1 (SGLT1), SLC2A2 (GLUT2), SLC2A5 (GLUT5), and TAS1R2/TAS1R3 taste receptors that sense luminal sugars.
• Intestinal hexose absorption is regulated by hormones such as cholecystokinin, which reduces SGLT1 abundance in the brush-border membrane.
• Disruptions in this process are linked to small intestinal diseases, including malabsorption syndromes and diabetes.
• Research models include knockout mice, point-mutation knock-in mice, and overexpression systems to study transporter function and regulation.
Description
Intestinal hexose absorption (GO:0106001) is a fundamental biological process responsible for the uptake of dietary hexoses, primarily D-glucose, fructose, and galactose, from the lumen of the small intestine into the bloodstream. This process is essential for providing energy to the body and maintaining glucose homeostasis. The absorption occurs through two main routes: a transcellular pathway involving specific transporters on the apical and basolateral membranes of enterocytes, and a paracellular pathway that allows hexoses to pass between cells. Understanding the molecular mechanisms of intestinal hexose absorption is critical for researchers studying metabolic disorders, gastrointestinal diseases, and nutritional physiology. The process is highly regulated and involves a complex interplay of transporters, hormones, and signaling pathways. Recent studies have highlighted the importance of sodium-dependent glucose transporters, such as SGLT1, and facilitative transporters, such as GLUT2, in mediating this process across different species and developmental stages. This article provides a comprehensive overview of the ontology, genes, functions, and research methods associated with GO:0106001, based on authoritative QuickGO data and verified PubMed literature.
intestinal hexose absorption At A Glance
| GO ID | GO:0106001 |
|---|---|
| GO term | intestinal hexose absorption |
| Ontology | biological_process |
| Synonym | None |
| Major function | Uptake of hexoses (D-glucose, fructose, galactose) from the small intestine into the blood |
| Related transporters | SGLT1 (SLC5A1), GLUT2 (SLC2A2), GLUT5 (SLC2A5) |
| Regulatory hormones | Cholecystokinin, insulin, glucagon-like peptide-2 |
| Associated diseases | Glucose-galactose malabsorption, diabetes, intestinal malabsorption |
| Research models | Knockout mice, point-mutation knock-in mice, overexpression cell lines |
What Is GO:0106001?
GO:0106001 intestinal hexose absorption is defined as the uptake of hexoses, notably D-glucose, fructose, and galactose, into the blood by absorption from the small intestine. This process encompasses the transport of these monosaccharides across the intestinal epithelium, primarily in the jejunum, and their subsequent entry into the circulation. The definition emphasizes the physiological outcome: the movement of hexoses from the intestinal lumen to the blood, which is essential for energy supply and metabolic regulation.
Why Is intestinal hexose absorption Important in Cell Biology?
Intestinal hexose absorption is vital for maintaining energy balance and glucose homeostasis in animals. Dysregulation of this process contributes to a range of pathological conditions, including glucose-galactose malabsorption, diabetes mellitus, and intestinal inflammatory diseases. Moreover, understanding the mechanisms of hexose absorption is crucial for developing therapeutic strategies to modulate glucose uptake in metabolic disorders. The process also exhibits developmental and species-specific adaptations, as shown in studies on tadpoles to frogs and broiler chickens, highlighting its evolutionary and physiological significance.
• Provides essential energy substrates for the body.
• Maintains blood glucose homeostasis.
• Dysregulation leads to glucose-galactose malabsorption and diarrhea.
• Implicated in the pathophysiology of type 2 diabetes and obesity.
• Target for nutritional and pharmacological interventions.
• Shows developmental regulation across metamorphosis.
• Species-specific differences inform comparative physiology.
• Hormonal control by cholecystokinin modulates transporter abundance.
• Paracellular route contributes to absorption under certain conditions.
• Genetic defects in transporters cause congenital malabsorption syndromes.
What Happens During intestinal hexose absorption?
Luminal Sensing and Transporter Recruitment
In simple terms: The intestine senses sugars in the food and prepares to absorb them.
Enteroendocrine cells and taste receptors detect luminal hexoses, leading to the recruitment of transporters to the brush-border membrane. The sodium-dependent glucose transporter SGLT1 (SLC5A1) is rapidly inserted into the apical membrane to facilitate glucose and galactose uptake. This step is critical for initiating active absorption.
Apical Uptake via Sodium-Dependent Transporters
In simple terms: Sugar molecules are pulled into the intestinal cells using sodium.
SGLT1 couples the transport of glucose and galactose with sodium ions, moving them from the lumen into the enterocyte against a concentration gradient. This secondary active transport is driven by the sodium gradient maintained by the Na+/K+-ATPase. Fructose, in contrast, is absorbed primarily via the facilitative transporter GLUT5 (SLC2A5).
Basolateral Exit via Facilitative Transporters
In simple terms: Sugar leaves the intestinal cell and enters the blood.
After entering the enterocyte, hexoses are transported across the basolateral membrane into the interstitial fluid and then into the blood. This exit is mediated by facilitative glucose transporters, primarily GLUT2 (SLC2A2), which facilitates the diffusion of glucose, galactose, and fructose down their concentration gradients.
Paracellular Transport
In simple terms: Some sugar leaks between cells directly into the blood.
Under certain conditions, such as high luminal glucose concentrations, hexoses can also be absorbed via the paracellular route, passing between enterocytes through tight junctions. This route is less regulated and may contribute significantly to overall absorption when transcellular pathways are saturated.
Regulation by Hormones and Neural Signals
In simple terms: Hormones can speed up or slow down sugar absorption.
Cholecystokinin decreases intestinal hexose absorption by reducing SGLT1 abundance in the brush-border membrane. Other hormones, such as insulin and GLP-2, also modulate transporter expression and activity. This regulation ensures that absorption matches the body's metabolic needs.
Key Genes Involved in GO:0106001 intestinal hexose absorption
The following genes encode key transporters and regulatory proteins involved in intestinal hexose absorption.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC5A1 (SGLT1) | Apical sodium-dependent glucose/galactose transporter | Mutations cause glucose-galactose malabsorption; target for diabetes drugs |
| SLC2A2 (GLUT2) | Basolateral facilitative glucose/fructose transporter | Defects lead to Fanconi-Bickel syndrome; regulates glucose homeostasis |
| SLC2A5 (GLUT5) | Apical facilitative fructose transporter | Essential for fructose absorption; linked to fructose intolerance |
| TAS1R2 | Sweet taste receptor subunit | Senses luminal sugars; modulates transporter expression |
| TAS1R3 | Sweet taste receptor subunit | Senses luminal sugars; modulates transporter expression |
| GNAS | G-protein alpha subunit | Mediates taste receptor signaling in enteroendocrine cells |
| CCK | Cholecystokinin hormone | Reduces SGLT1 abundance and hexose absorption |
| CCKAR | Cholecystokinin receptor | Mediates CCK effects on intestinal absorption |
| INS | Insulin | Regulates GLUT2 trafficking and expression |
| GCG | Glucagon | Counter-regulates glucose uptake |
| GLP2 | Glucagon-like peptide-2 | Enhances intestinal absorption and transporter expression |
| SLC9A3 | Na+/H+ exchanger | Indirectly supports sodium gradient for SGLT1 |
| ATP1A1 | Na+/K+-ATPase alpha subunit | Maintains sodium gradient for secondary active transport |
| CDX2 | Intestinal transcription factor | Regulates SLC5A1 and SLC2A2 expression |
| HNF4A | Hepatocyte nuclear factor 4 alpha | Regulates intestinal transporter gene expression |
| FOXA2 | Forkhead box A2 | Modulates intestinal differentiation and transporter expression |
| NEUROD1 | Neurogenic differentiation 1 | Regulates enteroendocrine cell function |
| PAX6 | Paired box 6 | Involved in gut development and transporter patterning |
How Is intestinal hexose absorption Regulated?
Intestinal hexose absorption is regulated at multiple levels. Hormonal control includes cholecystokinin, which decreases SGLT1 abundance in the brush-border membrane, thereby reducing glucose uptake. Insulin and glucagon-like peptide-2 (GLP-2) enhance transporter expression and activity, promoting absorption. Transcriptional regulation by factors such as CDX2 and HNF4A controls the expression of SLC5A1 and SLC2A2. Additionally, developmental changes, as seen during frog metamorphosis, alter the reliance on sodium-dependent glucose absorption. Luminal nutrient sensing via taste receptors also modulates transporter trafficking.
intestinal hexose absorption and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC5A1 | Glucose-galactose malabsorption | Knockout mouse, patient organoids |
| SLC2A2 | Fanconi-Bickel syndrome | Knock-in mouse with point mutation |
| SLC2A5 | Fructose intolerance | Overexpression cell lines, KO mice |
| CCK | Postprandial glucose regulation | CCK knockout mouse |
| TAS1R2/TAS1R3 | Sweet taste sensing and glucose homeostasis | Double knockout mouse |
Glucose-Galactose Malabsorption
Mutations in SLC5A1 (SGLT1) cause glucose-galactose malabsorption, a rare autosomal recessive disorder characterized by severe diarrhea and dehydration in infants fed glucose- or galactose-containing diets. The defect in apical glucose uptake leads to osmotic diarrhea and failure to thrive. Research models include knockout mice and patient-derived intestinal organoids to study the molecular basis and potential therapies.
Diabetes Mellitus and Metabolic Syndrome
Altered intestinal hexose absorption contributes to postprandial hyperglycemia in type 2 diabetes. Increased expression or activity of SGLT1 and GLUT2 has been observed in diabetic models, and SGLT1 inhibitors are being explored as therapeutic agents. The process is also linked to obesity and insulin resistance, making it a target for nutritional and pharmacological interventions.
Intestinal Malabsorption Syndromes
Conditions such as celiac disease, Crohn's disease, and short bowel syndrome can impair hexose absorption due to mucosal damage or reduced surface area. Understanding the adaptive responses of transporters in these conditions is crucial for managing nutritional deficiencies. Studies in animal models and human biopsies have revealed compensatory changes in SGLT1 and GLUT2 expression.
From intestinal hexose absorption-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Role of SGLT1 in glucose uptake | SLC5A1 knockout mouse |
| Effect of point mutation on transporter function | SLC5A1 point-mutation knock-in mouse |
| Regulation of GLUT2 trafficking | GLUT2-GFP knock-in mouse |
| Consequences of SGLT1 overexpression | Transgenic overexpression mouse |
| Hormonal regulation by CCK | CCK receptor knockout mouse |
| Developmental changes in absorption | Tadpole-to-frog metamorphosis model |
How to Study the intestinal hexose absorption Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ussing chamber | Transepithelial hexose flux | Studying active transport in intestinal segments |
| qPCR | mRNA expression of transporters | Quantifying SGLT1, GLUT2, GLUT5 levels |
| Western blot | Protein abundance | Assessing brush-border membrane SGLT1 |
| Immunohistochemistry | Tissue localization of transporters | Mapping SGLT1 and GLUT2 in villi |
| RNA-seq | Global gene expression | Identifying novel regulators of absorption |
| Proteomics | Protein composition of membranes | Discovering new transport partners |
| Live-cell imaging | Transporter trafficking | Visualizing SGLT1-GFP insertion |
| CRISPR screening | Gene function in absorption | Identifying modifiers of hexose uptake |
Using Ussing Chambers to Measure Transepithelial Transport
Ussing chambers allow measurement of active and passive hexose transport across intestinal segments. This technique has been used to study sodium-dependent glucose absorption in various species, including chickens and frogs. It provides real-time data on short-circuit current and flux rates, enabling researchers to dissect transcellular and paracellular contributions.
Molecular Analysis of Transporter Expression
Quantitative PCR, Western blotting, and immunohistochemistry are used to assess mRNA and protein levels of SGLT1, GLUT2, and GLUT5 in intestinal tissues. These methods have revealed hormonal regulation by cholecystokinin and developmental changes in transporter abundance. RNA-seq and proteomics can provide global views of transporter networks.
Genetic Models for Functional Studies
Knockout and transgenic mice are invaluable for studying the physiological roles of specific transporters. For example, SLC5A1 knockout mice exhibit glucose-galactose malabsorption, mimicking the human disease. Conditional and inducible systems allow temporal and tissue-specific manipulation. CRISPR/Cas9 technology has accelerated the generation of such models.
Imaging and Live-Cell Tracking
Fluorescently tagged transporters (e.g., SGLT1-GFP) enable live-cell imaging of trafficking and membrane insertion in response to stimuli. This approach has elucidated the rapid recruitment of SGLT1 to the brush-border membrane upon sugar sensing. Intravital microscopy can visualize absorption in real time in animal models.
How CRISPR Can Be Used to Study GO:0106001 intestinal hexose absorption
Knockout
CRISPR/Cas9-mediated knockout of SLC5A1, SLC2A2, or SLC2A5 in cell lines (e.g., Caco-2) or mice abolishes specific hexose transport activities, providing causal evidence for their roles. Knockout models are essential for studying compensatory mechanisms and disease phenotypes.
Point Mutation
Introducing disease-associated point mutations (e.g., in SLC5A1) via CRISPR base editing or homology-directed repair recapitulates human malabsorption syndromes in model systems. These models help dissect the functional impact of specific amino acid changes on transporter activity and trafficking.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous transporter loci allows real-time tracking of protein localization and dynamics without overexpression artifacts. This approach is valuable for studying regulated trafficking in response to nutrients and hormones.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of transporters such as SGLT1 can enhance absorptive capacity, useful for studying the effects of increased glucose uptake on metabolism and disease. Overexpression models also facilitate biochemical purification and structural studies.
How EDITGENE Supports intestinal hexose absorption Research
Researchers studying intestinal hexose absorption-related genes often need to determine whether a candidate gene is causally involved in transporter regulation, hexose flux, or disease pathogenesis. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for intestinal hexose absorption research.
Frequently Asked Questions About intestinal hexose absorption
What is GO:0106001 intestinal hexose absorption?
GO:0106001 is a Gene Ontology biological process term defined as the uptake of hexoses, notably D-glucose, fructose, and galactose, into the blood by absorption from the small intestine.
What genes are involved in intestinal hexose absorption?
Key genes include SLC5A1 (SGLT1), SLC2A2 (GLUT2), SLC2A5 (GLUT5), and taste receptors TAS1R2/TAS1R3, as well as hormones like CCK.
How is intestinal hexose absorption regulated?
It is regulated by hormones such as cholecystokinin, which reduces SGLT1 abundance, and by insulin and GLP-2, which enhance transporter expression.
What diseases are associated with defects in intestinal hexose absorption?
Mutations in SLC5A1 cause glucose-galactose malabsorption; altered absorption is linked to diabetes and intestinal malabsorption syndromes.
What research models are used to study intestinal hexose absorption?
Models include knockout mice, point-mutation knock-in mice, overexpression cell lines, and Ussing chamber experiments.
What is the role of SGLT1 in intestinal hexose absorption?
SGLT1 (SLC5A1) is the apical sodium-dependent glucose transporter that mediates active uptake of glucose and galactose from the intestinal lumen.
How does fructose get absorbed in the intestine?
Fructose is absorbed primarily via the facilitative transporter GLUT5 (SLC2A5) on the apical membrane of enterocytes.
Can CRISPR be used to study intestinal hexose absorption?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect the roles of transporters and regulatory genes.
What is the paracellular route of hexose absorption?
The paracellular route allows hexoses to pass between enterocytes through tight junctions, contributing to absorption especially at high luminal concentrations.
How does cholecystokinin affect hexose absorption?
Cholecystokinin decreases intestinal hexose absorption by reducing the abundance of SGLT1 in the brush-border membrane.
Conclusion
Intestinal hexose absorption (GO:0106001) is a critical biological process that ensures the uptake of dietary sugars into the bloodstream. It involves a coordinated interplay of apical and basolateral transporters, regulated by hormones and developmental cues. Dysregulation of this process underlies several human diseases, including glucose-galactose malabsorption and diabetes. Advances in CRISPR-based models and functional assays continue to unravel the molecular mechanisms, offering potential therapeutic targets. EDITGENE provides essential tools and services to support this research, from knockout cell lines to CRISPR library screening.
References
- 1. Cheeseman CI. 2002. Intestinal hexose absorption: transcellular or paracellular fluxes.. J Physiol 544(2):336 PMID: 12381808
- 3. Savory CJ et al.. 1991. Absorption of hexose and pentose sugars in vivo in perfused intestinal segments in the fowl.. Comp Biochem Physiol A Comp Physiol 100(4):969-74 PMID: 1685392
- 4. Hirsh AJ et al.. 1998. Cholecystokinin decreases intestinal hexose absorption by a parallel reduction in SGLT1 abundance in the brush-border membrane.. J Biol Chem 273(23):14545-9 PMID: 9603969
- 5. Thazhath SS et al.. 2014. Glucose absorption in small intestinal diseases.. Expert Rev Gastroenterol Hepatol 8(3):301-12 PMID: 24502537
- 7. Ishizuka N et al.. 2023. Na(+)-dependent intestinal glucose absorption mechanisms and its luminal Na(+) homeostasis across metamorphosis from tadpoles to frogs.. Am J Physiol Regul Integr Comp Physiol 324(5):R645-R655 PMID: 36939209
- 8. Shibata M et al.. 2023. Development of active jejunal glucose absorption in broiler chickens.. Poult Sci 102(8):102804 PMID: 37321034
